Clinical trials
Active, not recruiting Phase 3 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
444 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 10 |
| 2016 | 3 |
| 2017 | 13 |
| 2018 | 24 |
| 2019 | 19 |
| 2020 | 51 |
| 2021 | 67 |
| 2022 | 71 |
| 2023 | 78 |
| 2024 | 69 |
| 2025 | 25 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 444 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 62 |
| Hoffmann-La Roche | 42 |
| Merck Sharp & Dohme LLC | 28 |
| Janssen Research & Development, LLC | 27 |
| Novartis Pharmaceuticals | 25 |
| Eli Lilly and Company | 18 |
| AbbVie | 16 |
| Bristol-Myers Squibb | 16 |
| Amgen | 12 |
| Sanofi | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 47 |
| Breast Neoplasms | 32 |
| Prostatic Neoplasms | 16 |
| Neoplasm Metastasis | 15 |
| Neoplasms | 14 |
| Multiple Myeloma | 13 |
| Recurrence | 10 |
| Carcinoma, Renal Cell | 9 |
| Lupus Erythematosus, Systemic | 9 |
| Lymphoma, Non-Hodgkin | 9 |
Trials
Showing 1 to 25 of 444. Each trial links to its page on Pharma Observatory.
344 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.